IDNs Will Use AI, Other Tools To Improve Cell and Gene Therapies
Originally published by our sister publication Specialty Pharmacy ContinuumMarcus A. BanksIntegrated delivery networks (IDNs) will be critical in improving access to cell and gene therapies in the coming years, with artificial intelligence and data-mining of electronic health records (EHRs) among the tools they will use to optimize outcomes, according to panelists at Asembia’s AXS25 Summit, in Las Vegas.IDNs will need to harness data from payors and manufacturers to streamline access to th
Read more »